ABN AMRO Bank N.V. Grows Stock Holdings in Oracle Corporation $ORCL

ABN AMRO Bank N.V. lifted its stake in shares of Oracle Corporation (NYSE:ORCL) by 191.7% during the third quarter, HoldingsChannel.com reports. The fund owned 20,313 shares of the enterprise software provider’s stock after buying an additional 13,350 shares during the quarter. ABN AMRO Bank N.V.’s holdings in Oracle were worth $5,707,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. HighPoint Advisor Group LLC grew its stake in Oracle by 2.1% in the third quarter. HighPoint Advisor Group LLC now owns 42,564 shares of the enterprise software provider’s stock worth $11,971,000 after purchasing an additional 862 shares in the last quarter. Linscomb Wealth Inc. raised its position in Oracle by 2.4% during the 3rd quarter. Linscomb Wealth Inc. now owns 46,236 shares of the enterprise software provider’s stock valued at $13,003,000 after purchasing an additional 1,074 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S lifted its holdings in shares of Oracle by 20.2% in the 3rd quarter. BI Asset Management Fondsmaeglerselskab A S now owns 323,834 shares of the enterprise software provider’s stock worth $91,075,000 after buying an additional 54,326 shares during the period. SBI Securities Co. Ltd. lifted its holdings in shares of Oracle by 129.1% in the 3rd quarter. SBI Securities Co. Ltd. now owns 25,848 shares of the enterprise software provider’s stock worth $7,269,000 after buying an additional 14,564 shares during the period. Finally, Howe & Rusling Inc. grew its position in shares of Oracle by 10.5% during the 3rd quarter. Howe & Rusling Inc. now owns 6,890 shares of the enterprise software provider’s stock worth $1,938,000 after buying an additional 654 shares in the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle Stock Down 5.1%

NYSE:ORCL opened at $146.75 on Thursday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 3.28. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The company has a market cap of $421.63 billion, a PE ratio of 27.58, a P/E/G ratio of 1.35 and a beta of 1.64. The company’s 50 day moving average is $191.31 and its two-hundred day moving average is $235.52.

Oracle (NYSE:ORCL) last posted its quarterly earnings data on Wednesday, December 10th. The enterprise software provider reported $2.26 EPS for the quarter, topping the consensus estimate of $1.64 by $0.62. The business had revenue of $16.06 billion during the quarter, compared to the consensus estimate of $16.19 billion. Oracle had a net margin of 25.28% and a return on equity of 70.60%. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.47 earnings per share. Analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 23rd. Shareholders of record on Friday, January 9th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date was Friday, January 9th. Oracle’s payout ratio is presently 37.59%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ORCL. JMP Securities restated a “market outperform” rating and issued a $342.00 price objective on shares of Oracle in a report on Friday, October 17th. BMO Capital Markets cut their target price on shares of Oracle from $270.00 to $205.00 and set an “outperform” rating on the stock in a research report on Wednesday. Weiss Ratings lowered shares of Oracle from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, January 23rd. JPMorgan Chase & Co. lowered their price target on shares of Oracle from $270.00 to $230.00 and set a “neutral” rating for the company in a research report on Thursday, December 11th. Finally, TD Cowen cut their price objective on shares of Oracle from $400.00 to $350.00 and set a “buy” rating on the stock in a report on Thursday, December 11th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $296.03.

Key Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle Health won a multi-organization pilot in Canada for its Clinical AI Agent, validating commercial traction for Oracle’s healthcare AI products. Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent
• Positive Sentiment: Oracle’s recent $25B bond offering reportedly attracted heavy demand, indicating strong investor appetite for its debt and suggesting financing channels are open. Oracle Stock (ORCL) Gains as $25B Bond Offering Attracts Heavy Demand
• Positive Sentiment: Some sell-side firms (e.g., Barclays) have reiterated bullish ratings and high price targets, implying analysts still see upside if Oracle executes its AI/data-center strategy. Barclays Reiterates Overweight on Oracle
• Neutral Sentiment: Oracle announced an equity distribution agreement and senior notes issuance to fund its plans — this provides capital but increases near-term financing activity and complexity. Oracle Bolsters Financing with Major Senior Notes Issuance
• Neutral Sentiment: Oracle continues product and go-to-market pushes (AI banking platform, enterprise AI agents) that could drive long-term growth but require heavy near-term capex. Oracle Reimagines Banking for the AI Era
• Neutral Sentiment: Strategic commentary ties Oracle’s massive data-center and power plans to a structural shift (e.g., MarketBeat piece on companies funding power and SMRs); long-term strategic rationale exists but is execution- and timeline-dependent. The Atomic Pivot: AI’s $50 Billion Power Move
• Negative Sentiment: Markets punished Oracle after management outlined plans to raise roughly $45–50B for AI infrastructure (debt and equity), stoking dilution and leverage fears and sparking the recent sell-off. Oracle (ORCL) Is Down 11.6% After Unveiling a US$45–50 Billion AI Infrastructure Capital Plan
• Negative Sentiment: Multiple law firms have filed or are soliciting clients for securities class actions tied to Oracle’s disclosures (senior notes/offering documents and the June–Dec 2025 class period), adding legal risk and headline pressure. Kessler Topaz Files Securities Fraud Class Action Against Oracle
• Negative Sentiment: Reports say banks are exploring selling billions in loans tied to Oracle’s data centers and the company may cut up to 30,000 jobs — both raise execution and integration risks and amplify downside sentiment. Oracle Stock (ORCL) Slips as Banks Explore Selling Its Data Center Loans Oracle May Slash Up to 30,000 Jobs
• Negative Sentiment: Analysts have trimmed price targets (BMO, Scotiabank among them) and commentary highlights investor anxiety about the size/timing of the capital raise and AI execution — contributing to the stock’s decline. Oracle Price Target Lowered at BMO

Insider Transactions at Oracle

In related news, CEO Clayton M. Magouyrk sold 10,000 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $192.52, for a total value of $1,925,200.00. Following the transaction, the chief executive officer owned 144,030 shares in the company, valued at approximately $27,728,655.60. This represents a 6.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Naomi O. Seligman sold 2,223 shares of the stock in a transaction on Tuesday, December 23rd. The stock was sold at an average price of $196.61, for a total transaction of $437,064.03. Following the completion of the sale, the director owned 25,596 shares in the company, valued at $5,032,429.56. The trade was a 7.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 62,223 shares of company stock valued at $12,136,764 over the last three months. Company insiders own 40.90% of the company’s stock.

Oracle Company Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.